Alan A. Musso

Insider Reports History

Entity
Individual
Location
Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge, MA
Signature
/s/ Brian Windsor, attorney-in-fact for Alan A. Musso
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan A. Musso:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 100K Jan 26, 2024 Direct
Aileron Therapeutics, Inc. Director Stock Option (right to buy) 35K Dec 2, 2024 Direct
Fulcrum Therapeutics, Inc. Chief Financial Officer No securities are beneficially owned 0 Aug 7, 2023 Direct

Insider Reports Filed by Alan A. Musso

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALRN Aileron Therapeutics, Inc. Dec 2, 2024 1 $0 4 Dec 6, 2024 Director
ALRN Aileron Therapeutics, Inc. Aug 20, 2024 1 $0 4 Aug 22, 2024 Director
FULC Fulcrum Therapeutics, Inc. Jan 26, 2024 1 $0 4 Jan 30, 2024 Chief Financial Officer
FULC Fulcrum Therapeutics, Inc. Jan 17, 2024 1 $0 4 Jan 19, 2024 Chief Financial Officer
ALRN AILERON THERAPEUTICS INC Oct 31, 2023 1 $0 4 Nov 2, 2023 Director
ALRN AILERON THERAPEUTICS INC Oct 31, 2023 0 $0 3 Nov 2, 2023 Director
FULC Fulcrum Therapeutics, Inc. Aug 7, 2023 1 $0 4 Aug 9, 2023 Chief Financial Officer
FULC Fulcrum Therapeutics, Inc. Aug 7, 2023 0 $0 3 Aug 9, 2023 Chief Financial Officer